APA

Eron J. J., Cooper D. A., Steigbigel R. T., Clotet B., Gatell J. M., Kumar P. N., Rockstroh J. K., Schechter M., Markowitz M., Yeni P., Loutfy M. R., Lazzarin A., Lennox J. L., Strohmaier K. M., Wan H., Barnard R. J. O., Nguyen B. T. & Teppler H. (20130904). Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials. : The Lancet. Infectious diseases.

Chicago

Eron Joseph J, Cooper David A, Steigbigel Roy T, Clotet Bonaventura, Gatell Jose M, Kumar Princy N, Rockstroh Jurgen K, Schechter Mauro, Markowitz Martin, Yeni Patrick, Loutfy Mona R, Lazzarin Adriano, Lennox Jeffrey L, Strohmaier Kim M, Wan Hong, Barnard Richard J O, Nguyen Bach-Yen T and Teppler Hedy. 20130904. Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials. : The Lancet. Infectious diseases.

Harvard

Eron J. J., Cooper D. A., Steigbigel R. T., Clotet B., Gatell J. M., Kumar P. N., Rockstroh J. K., Schechter M., Markowitz M., Yeni P., Loutfy M. R., Lazzarin A., Lennox J. L., Strohmaier K. M., Wan H., Barnard R. J. O., Nguyen B. T. and Teppler H. (20130904). Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials. : The Lancet. Infectious diseases.

MLA

Eron Joseph J, Cooper David A, Steigbigel Roy T, Clotet Bonaventura, Gatell Jose M, Kumar Princy N, Rockstroh Jurgen K, Schechter Mauro, Markowitz Martin, Yeni Patrick, Loutfy Mona R, Lazzarin Adriano, Lennox Jeffrey L, Strohmaier Kim M, Wan Hong, Barnard Richard J O, Nguyen Bach-Yen T and Teppler Hedy. Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials. : The Lancet. Infectious diseases. 20130904.